immuno-oncology

Pharma

Another AstraZeneca Emerald glimmers in liver cancer

Another green light appears increasingly within reach for AZ’s Emerald program, as Imfinzi and Imjudo showed a PFS benefit in locoregional liver cancer.

Angus Liu Apr 2, 2026 10:12am

Graphic of a fork in the road with arrows pointing in either direction

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm

BioNTech works to diversify supply base ahead of oncology launch

May 5, 2025 10:36am

layoffs job cuts fired exit restructuring layoff reduction

Coherus loses commercial chief amid exit from biosimilar space

Apr 23, 2025 11:19am

BMS follows Roche, AstraZeneca into first-line liver cancer

Apr 11, 2025 1:53pm

ImmunityBio, SII win FDA nod to help combat BCG shortage

Feb 19, 2025 9:01am